Phase I medium: Advanced RPMI 1640 medium – – 9.791 ml; GlutaMAX-I (100×) 100× 1× 100 μl; Pen-strep (100×) 100× 1× 100 μl; CHIR99021 10 mM 8 μM 8 μl; LDN193189 10 μM (second stock) 10 nM 1 μl. Phase II medium: Advanced RPMI 1640 medium – – 9.788 ml; GlutaMAX-I (100×) 100× 1× 100 μl; Pen-strep (100×) 100× 1× 100 μl; Y-27632 10 mM 10 μM 10 μl; Activin A 50 μg ml−1 10 ng ml−1 2 μl. Phase III medium: Advanced RPMI 1640 medium – – 9.795 ml; GlutaMAX-I (100×) 100× 1× 100 μl; Pen-strep (100×) 100× 1× 100 μl; FGF9 100 μg ml−1 50 ng ml−1 5 μl.
